VELA Investment Management, LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1895612
NEW ALBANY, OH
Position in AXSM
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$293,724
+$293,724 QoQ
Shares Held
1,200
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#377
of 503 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in AXSM
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$293,724
PutShares
1,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026VELA Investment Management, LLC holds $500,720 across 2 Biotechnology names. AXSM ranks #1 (58.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
This page
|
1,200 | $293,724 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
5,849 | $206,996 |
All Filings in AXSM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $293,724 | 1,200 | Put | Sole | 2026-08-03 | |
| 2026-06-30 | $293,724 | 1,200 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $338,040 | 2,000 | Call | Sole | 2026-08-27 | |
| 2025-12-31 | $730,560 | 4,000 | Call | Sole | 2026-08-27 | |
| 2025-09-30 | $364,350 | 3,000 | Call | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||